Volatility Stories

From a volatility viewpoint, Fortress Transp Infra (FTAI) has shown a promising low-risk outlook, with a Coefficient of Variation at 606.68 and a Sortino Ratio of 0.1433, indicating a relatively stable performance. The stock's Day Typical Price stands at $33.4, with an Open Price slightly higher at $33.56. The Downside Variance, a measure of the potential loss an investment can make, is relatively low at 2.9, further enhancing the stock's low-risk profile.

WSFS Financial currently has approximately $1.03 billion in cash, with $480.85 million of positive cash flow from operations. This results in a cash-per-share (CPS) ratio of 16.56.

Detailed assessment

Investors considering WSFS Financial stock should take note of its volatility metrics. The company's Coefficient of Variation stands at a significant 1.4K, indicating a high level of risk relative to the expected return.

Cleveland Cliffs (CLF) is a stock that has been showing significant volatility, with a standard deviation of 2.4, indicating a higher risk and potential for higher returns. The stock's kurtosis is 0.4563, suggesting a relatively normal distribution of returns, and a skewness of 0.2327, indicating a slight lean towards positive returns. However, investors should be aware of the stock's Value At Risk (VaR) of 3.93, which represents the potential loss that could occur with a 5% probability.

Schlumberger NV holds approximately $2.89 billion in cash, with a positive cash flow from operations of $3.72 billion. This results in a cash-per-share (CPS) ratio of 2.55.

Additional examination

Schlumberger NV, a key player in the Oil & Gas Equipment & Services industry, has seen a significant drop in volatility, presenting a potentially attractive investment opportunity. The company's Mean Deviation has plummeted to a low 1.63, compared to the Standard Deviation of 2.26, suggesting a more stable performance.

Farmers Merchants Bancorp (FMAO), a key player in the Banks-Regional industry, has been a topic of interest for investors due to its notable volatility. The company, with a fiscal year end in December, has seen its stock fluctuate, presenting both risks and opportunities for traders. The company's valuation real value stands at $22.16, while its valuation market value is slightly higher at $23.83.

Lockheed Martin holds approximately $2.55 billion in cash, with a positive cash flow from operations of $7.8 billion. This results in a cash-per-share (CPS) ratio of 9.27.

Progressive assessment

Lockheed Martin (LMT) has been a stable player in the Aerospace & Defense industry, with a low mean deviation of 0.80 and a standard deviation of 1.03, indicating a low-risk outlook. However, the company's negative Jensen Alpha of -0.08 and Treynor Ratio of -0.07 suggest underperformance when adjusting for risk.

PNC Financial Services holds approximately $7.03 billion in cash, with a positive cash flow from operations of $9.08 billion. This results in a cash-per-share (CPS) ratio of 17.39.

Further analysis

As we navigate through the current market volatility, PNC Financial Services (USA Stocks:PNC) presents an interesting case for investors. With a coefficient of variation standing at 1.3K, the stock demonstrates a significant level of price volatility, which is further confirmed by a standard deviation of 1.98.

Bank of America (BAC) has been showing a low-risk investment outlook, with a valuation hype value of 29.44 and a naive expected forecast value of 30.42. The bank's stock, traded on the NYSE, closed at a typical day price of 29.36, slightly below its valuation market value of 29.4. Analysts have mixed views on the stock, with 10 strong buys, 1 buy, 7 holds, 1 sell, and 1 strong sell.

Universal Health Services (NYSE: UHS), a prominent player in the Healthcare sector and Medical Care Facilities industry, has been experiencing significant stock volatility. Despite a challenging fiscal year ending in December, the company's real value is estimated at $163.57, notably higher than its current market value of $153.68. This discrepancy suggests potential for a strong rebound in August.

Liminal BioSciences (NASDAQ: LMNL), a key player in the Biotechnology & Medical Research industry, has been exhibiting significant volatility, raising concerns about a potential dip in August. The company's valuation metrics reveal a slight discrepancy between the market value of $8.36 and the real value of $8.32, suggesting a potential overvaluation. The analyst consensus, based on a single estimate, holds the stock at a target price of $7.5, indicating a possible downside from the current market value.